SCHEMBL2287233

SCHEMBL2287233

CCOC(=O)C(CNC(=O)OC(C)(C)C)c1c(F)ccc2cnc(OC)nc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.34
SYK P43405 1/20 0.34
AAK1 Q2M2I8 7/20 0.33
MAPT P10636 3/20 0.33
KDM4E B2RXH2 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SERPINE1 P05121 1/20 0.32
SCN5A Q14524 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
KCNH2 Q12809 1/20 0.32
PCSK9 Q8NBP7 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ALOX5AP P20292 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2289667 0.85 SCN9A (0.34) SCN9ASYKSERPINE1SCN5AKCNH2
SCHEMBL2285150 0.81 ALDH1A1 (0.34) SCN9AMAPTKDM4ESCN5AKCNH2
SCHEMBL1722764 0.81 KCNH2 (0.45) SCN9AAAK1KCNH2
SCHEMBL1712486 0.81 MTNR1A (0.39) SCN9ASYKAAK1SERPINE1PCSK9
SCHEMBL2292326 0.79 ALDH1A1 (0.34) MAPTKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL2293987 0.79 ALDH1A1 (0.34) MAPTKCNH2ALDH1A1CYP1A2CYP3A4
SCHEMBL2292775 0.79 SCN9A (0.36) SCN9AKDM4ESCN5AKCNH2L3MBTL1
SCHEMBL2292765 0.78 ROCK2 (0.36) SCN9AAAK1KDM4ENPSR1ALDH1A1
SCHEMBL1712060 0.72 MTNR1A (0.40) SCN9ASYKKDM4ESERPINE1PCSK9
SCHEMBL1711953 0.71 MTNR1A (0.39) SCN9ASYKPCSK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8618092-B2 Tricyclic oxazolidinone antibiotic compounds ACTELION PHARMACEUTICALS LTD. (CH) 2013-12-31 US disclosed
US-20110195961-A1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS ACTELION PHARMACEUTICALS LTD. (CH) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195961-A1 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS HRH3, OXA1L, HRH1 SCN9A 458/4885SYK 3334/4885AAK1 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.